Real-time · AI · Cross-signal

Biotech startup just raised. Here's exactly what to do next.

Who to reach, what to say, and why now — on Biotech startup, plus every funding round, exec hire, and M&A move that follows. Verified, ICP-ranked contacts on demand (email + mobile).

Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.

Choose your plan Request a demo

Everyone else gives you a piece

✕Crunchbase & PitchBook list the company — No person, no timing, no opener.

✕ZoomInfo & Apollo sell you a contact — No trigger, no reason to reach out now.

✕LinkedIn Sales Navigator shows you people — No real-time signal, no opener.

✕Clay enriches lists you built — No live signal of its own, no who or when.

✕ChatGPT & gen-AI tools answer on a delay — No live data, no verified contact.

Who to contactWhat to sayWhen to reach outWhy now

Only Fundz delivers all four.

Biotech startup raises $80m for leukemia drug funding.

PRIVATESep 05, 2025•9 months ago

Amount Raised

$80 Million

Description

Biotech startup has successfully raised $80 million to develop a new drug for leukemia. This funding will accelerate research and bring the product closer to market. The round attracted significant investor interest. The funds will be used primarily for clinical trials.

Biotech startup just raised. Here's exactly what to do next.

Biotech startup raises $80m for leukemia drug funding.

Description

Company Information

Funding Insights